Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT Capsule vs Colonoscopy for Recurrent CDI
NCT02254811Phase 3Completed
- Sponsor
- University of Alberta
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in Clostridium difficile infection (CDI), sponsored by University of Alberta. Started Sep 2014; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02254811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254811.